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Abstract: The first generation strategies toward the total synthesis of brevetoxin B (1) are presented and the syntheses 
of the key intermediates 3, 4, 5, 67, 83, and 94—98 required for the projected construction are described. The 
earliest and most convergent strategy required the application of the hydroxy epoxide cyclization and the intramolecular 
conjugate addition as key reactions for the construction of the fused tetrahydropyran ring systems (4) [ABC], (7) 
[FG], and (8 ) [UK], The oxocene ring (H) was formed via a Wittig reaction followed by a hydroxy dithioketal 
cyclization to produce the hexacyclic fragment [FGHUK] ( 6  — 5), The 12-membered dithionolactone 18 was 
envisioned as the precursor of the dioxepane system of the molecule via a projected bridging reaction, to construct 
simultaneously both oxepane rings. However, the dithionation of dilactone 17 proved unsuccessful. In a subsequently 
evolved strategy, a new photolytic approach toward the dioxepane region was developed, starting from the acyclic 
dithiono progenitor 20 (20 —* 23). Application of this reaction to the brevetoxin B skeleton afforded the desired 
oxepene (96 —* 97), which after deprotection produced oxepanone 98. A specifically designed reductive hydroxy 
ketone cyclization (98 —1 99) was then employed in an attempt to close the remaining ring [E], but, again, without 
success. The novel rearrangement of hydroxy ketone 87 to the pentacyclic system 89 was observed in a less elaborate 
skeleton. The scope and generality of these silicon-induced reductive cyclizations are also described.
Introduction
“Red tides*1 is the name used to describe vast blooms of 
unicellular algae (phytoplankton) which constitute the base of 
the marine food chain. The name is derived from the color of 
certain of these blooms even though in the broader sense the 
term includes other colorations and colorless outbreaks, These 
phenomena are often associated with catastrophic consequences 
for marine and land life, including humans. 1 Among the earliest 
episodes of “red tide” phenomena is a 1793 incident in Canada, 
involving Captain George Vancouver and his crew who suffered 
poisoning upon seafood consumption in the coastal area of 
British Columbia.2 Next to be recorded were two incidents in 
1972, the first along the coast of New England following a 
severe hurricane originating in the Gulf of Mexico and allegedly 
carrying the poisonous algae with it, and the second in the Seto 
Inland Sea, off the coast of Japan, where more than half a billion 
dollars worth of caged yellow-tail fish perished. In the period 
1987-1988, several incidents occurred, in which mussels, fish, 
dolphins, whales, and humans were fatally affected in the US 
and Canada .2 In 1991 a “red tid?M occurrence was responsible 
for hundreds of sick and dying pelicans found on the beaches 
near Monterey, CA .2 Responsible for the catastrophic effects 
of the “red tide" phenomena are a class of biotoxins, among 
which the brevetoxins constitute a prominent subclass.
Brevetoxin B (1, Scheme 1), the first and most prominent 
member of the brevetoxin family, produced by the dinoflaggelate
Scheme 1, Structure of Brevetoxin B (1) and of Hypothetical 
Poly epoxide Precursors 2a and 2b
* Address correspondence to this author at either The Scripps Research 
Institute or The University of California, San Diego.
•Abstract published in Advance ACS Abstracts, October I, 1995.
(1) International Symposium on Red Tides', Qkaichi, T., Anderson, D. 
M., Nemoto, T., Eds.; Elsevier; New York, 1989.
(2) Anderson, D. M. Sci Ant 1994, 8> 62. Anderson, D. M.; White, A.
W. Oceanus 1992, 35, 55 and references cited therein.
2b; hypothetical poly»poxldo precursor
Ptychodiscus brevis Davis (Gymnodinium breve Davis) was 
isolated and characterized by spectroscopic and X-ray crystal- 
lographic means in 1981 by the groups of Lin, Nakanishi, and 
Clardy.3 Its highly complex molecular architecture is character­
ized by a novel array of ether oxygen atoms, regularly placed 
on a single carbon chain. This remarkable structure includes
0002-7863/95/1517-10227$09.00/0 © 1995 American Chemical Society
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1 1 rings, 23 stereogenic centers, and 3 carbon-carbon double 
bonds. Furthermore, brevetoxin B (1 ) exhibits intriguing 
regularity with regard to its ring fusions which are all trans, its 
rings, each of which contains a single oxygen, and its ring 
oxygens, all pairs of which are separated by a C—C bond. All 
substituents flanking the ring oxygens are syn to each other 
except those on ring K which are antL Although the structure 
of brevetoxin B (1) was unprecedented at the time of its 
discovery, its unique patterns were subsequently found in several 
marine natural products including brevetoxin A ,4 ciguatoxin,5 
gambieric acids,6 yessotoxin,7  and maitotoxin. 8
Brevetoxin B (1) exhibits potent neurotoxicity, exerting its 
biological action by binding to sodium channels, keeping them 
open and causing continuous and damaging sodium ion influx.9  
Its unique and fascinating molecular architecture, its association 
with the “red tide” catastrophes, and its novel mechanism of 
action as a biotoxin prompted intense investigations in both 
chemistry10 and biology. 11 In this series of papers12,13 we 
describe the total synthesis of brevetoxin B (1), placing special 
emphasis on the development of new synthetic technologies and 
the evolution of the strategies that eventually led to success.
Retrosynthetic Analysis and Strategy
A brief inspection of the brevetoxin B (1) structure leads to 
the intriguing and tempting idea of polycpoxides 2 a and 2 b 
(Scheme 1) serving as potential precursors via “zip” type 
reactions as indicated. 14 The question of whether Nature uses 
any of these pathways for the biosynthesis of brevetoxin B (1)
(3) Lin, Y.-Y.; Risk, M.; Ray, S. M.; Van Engen, D.; Clardy, J.; Golik, 
J.; James, J, C,; Nakanishi, K. J. Am. Chem. Soc. 1981,103,6773. Lee, M. 
S.; Repeta, D. J.; Nakanishi, K.; Zagorksi, M. G. J. Am. Chem, Soc, 1986, 
108, 7855.
(4) Shimizu, Y.; Chou, H. N.; Bando, H.; Van Duyne, G.; Clardy, J. C. 
J. Am. Chem. Soc. 1986, 108, 514. Sec also: Pawlak, M.; Tempesta, M. 
S.; Goiik, J.; Zagorski, M. G.; Lee, M.S.; Nakanishi, K.; Iwashita, T.; Gross, 
M. L.; Tomer, K, B. /. Am. Chem, Soc, 1987, 109, U44.
(5) Murata, M.; Legrand, A. M.; Ishibashi, Y.; Fukui, M.; Yasumoto, T, 
J. Am, Chem. Soc. 1990, 112, 4380.
(6) Nagai, H.; Torigoe, K.; Satake, M.; Murata, M.; Yasumoto, T.; Hirota, 
H. J. Am. Chem. Soc. 1992, 114, 1102.
(7) Murata, M.; Kumagai, M.; Lee, J. S.; Yasumoto, T, Tetrahedron Lett. 
1987, 28, 5869.
(8) Murata, M.; Naoki, H.; Matsunaga, M.; Satake, M.; Yasumoto, T. J. 
Am. Chem. Soc. 1994,116, 7098 and references cited therein.
(9) Strichartz, G.; Castle, N. in Marine Toxins: Origin, Structure and 
Molecular Pharmacology: Sherwood, H.; Strichartz, G.f Eds.; ACS 
Symposium Series 418; American Chemical Society: Washington, DC, 
1990; pp 3-20; Poli, M. A.; Mende, T. J.; Baden, D> G, Mol Pharmacol.
. 1986, 30, 129.
(10) Shimizu, Y. Pure Appl Chem. 1982, 54, 1973. Yasumoto, T.; 
Murata, M. Chem. Rev. 1993, 93, 1897. Nakanishi, K. Toxicon 1985, 23, 
473. Scheuer, P. J. Tetrahedron 1994, 50, 3. Kadota, I.; Matsukawa, Y.; 
Yamamoto, Y, J. Chem. Soc,, Chenu Commun, 1993, 1638. Palazon, J. 
M.; Soler, M. A.; Ramirez, M. A.; Martin, V. S. Tetrahedron Lett. 1993, 
34, 5467. Yamamoto, Y.; Yamada, J.; Kadota, I. Tetrahedron Lett 1991, 
32, 7069. Feng, F.; Murai, A. Chem. Lett, 1992, 1587. Alvarez, E.; Diaz,
M. T.; Perez, R.; Ravclo, J. L.; Regeiro, A.; Vera, J. A.; Zurita, D.; Martin, 
J. D. J. Org. Chem. 1994, 59, 2848.
(11) Toxic DinoJíagellates\ Anderson, D. M., White, A. W„ Baden, D. 
G., Eds.; Elsevier: Amsterdam, 1985. Marine Toxins: Origin, Structure 
and Molecular Pharmacology; Sherwood, H.; Strichartz, G., Eds.; ACS 
Symposium Series 418; American Chemical Society: Washington, DC, 
1990. Rein, K. S.; Baden, D, G.; Gawley, R. E. J. Org. Chem. 1994, 59, 
2101. Rein, K. S.; Lynn, B.; Gawley, R. E.; Baden, D. G. J. Org. Chem, 
1994, 59, 2107. Baden, D. G.; Mende, T. J.; Szmant, A. M.; Trainer, V. 
L.; Edwards, R. A.; Roszell, L. E. Toxicon 1988, 26t 972. Catterall, W, A. 
Annu. Rev. Biochem, 1986, 55, 953. Trainer, V. L.; Thomsen, W. J.; 
Catterall, W. A.; Baden, D. G. Mol. Pharmacol. 1991, 40, 988.
(12) Nicolaou, K. C.; Theodorakis, E. A.; Rutjes, F. P. J. T.; Sato, M.; 
Tiebes, J.; Xiao, X.-Y,; Hwang, C.-K.; Duggan, M. E.; Yang, Z.\ 
Couladouros, E, A.; Sato, F.; Shin, J.; He, H.-M.; Bleckman, T. J. Am. 
Chem. Soc. 1995, 117, 10239-10251.
(13) Nicolaou, K. C.; Rutjes, F. P. J. T.; Theodorakis, E. A.; Tiebes, J.; 
Sato, M.; Unterstcller, E. J. Am. Chem. Soc. 1995, 117, 10252-10263.
Scheme 2. Retrosynthetic Analysis and Strategic Bond 
Disconnections of Brevetoxin B (1): First Generation 
Approach
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has not been experimentally proven, as yet. 15 Furthermore, 
the possibility of such ambitious operations in the laboratory 
by chemical means, given our present limitations, was quickly 
discarded as remote at best. A more realistic and highly 
convergent approach was, therefore, sought. The first retrosyn­
thetic analysis of brevetoxin B (1) (Scheme 2) was based on 
three important reactions, each of which was developed for the
(14) Krishna Prasad, A. V,; Shimizu, Y. J, Am, Chem. Soc. 1989, 111, 
6476. Nakanishi, K. Toxicon 1985, 23, 473. Lee, M. S.; Qin, G.-W.; 
Nakanishi, K.; Zagorski, M. G. J, Am. Chem. Soc. 1989, 111, 6234. 
Townsend, C. A.; Basak, A. Tetrahedron 1991, 47, 2591. For a unified 
model for polyether antibiotics biosynthesis, see:. Cane, D. E.; Celmer, W. 
D.; Westley, J. W. J. Am. Chem. Soc. 1983,105, 3594 and references cited 
therein.
(15) For other references regarding the biosynthesis of brevetoxins, see: 
Garson, M. J. Chem. Rev. 1993, 93, 1699.
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specific purpose of addressing the total synthesis of brevetoxin 
B (1). These new reactions were the following: (a) the 
regioselective and stereo specific opening of hydroxy epoxides 
for the construction of tetrahydropyran systems; 16 (b) the facile 
cyclization of hydroxy dithioketals to form oxocene systems;17 
and (c) the bridging of macrocycles to bicycles, 18 Thus, 
removing the two ends of the molecule from the polycyclic 
skeleton and rupturing retro synthetically the central dioxepane 
C —C bond leads to the 12-membered ring dithionolactonc 3 as 
a potential progenitor of brevetoxin B (1). Disassembly of the 
latter intermediate (3) as indicated in Schemc 2  unravels the 
ABC ring system 4, or its demethoxy derivative, and the 
FGHUK ring system 5 as precursors, reducing the level of 
complexity of the target molecule (1) considerably. Applying 
the powerful retro hydroxy dithioketal cyclization reaction 
followed by a retro Wittig coupling leads rapidly to key 
intermediates FG (7) and UK (8 ) via hydroxy dithioketal 6 . 
Finally, the two tetrahydropyran-containing fragments 7 and 8  
can be traced back to the readily available starting materials, 
geraniol (9) 19 and D-mannose (10) , 20 respectively via hydroxy 
epoxide cyclizations and hydroxy a,/3-unsaturated ester conju­
gate additions, as indicated (Scheme 2).
Encouraged by the results of relevant model studies and with 
confidence in the convergent strategy derived from the analysis 
of Scheme 2, we proceeded to test the designed, first generation 
route toward brevetoxin B (1) as described below.
Synthesis of the FG H U K  Ring System
The cpnvergent synthesis of the FGHUK ring system 5 is 
summarized in Scheme 3. The constructions of the requisite 
FG 19 and UK20 frameworks 7 and 8  have been described 
previously. Wittig coupling of phosphonium salt 7 with 
aldehyde 8  proceeded smoothly under conditions favoring (Z)- 
double bond formation (n-BuLi, HMPA, THF, -7 8  °C) to afford 
olefin 11 in 70% yield. The (Z)-geometry of the generated 
double bond was confirmed by !H NMR decoupling experiments 
revealing a coupling constant of J =  11.5 Hz. Removal of the 
TMS group from 11 followed by AgClCVNCS^-induced ring 
closure resulted in the formation of oxocene 12 (78%, yield 
unoptimized), from which the ethylthio group was reductively 
removed using PhaSnH—AIBN furnishing compound 13 (92%) 
as a single stereoisomer. The desired trans stereochemistry at 
the newly generated ring junction was proven by ]H NMR 
decoupling experiments (J =  8,1 Hz, compare J — 7.9 Hz for 
brevetoxin B). Jones oxidation of 13 led directly to the 
corresponding carboxylic acid and then to methyl ester 14 
(CH2N2 , 80% overall yield). Finally, selective removal of the 
benzyloxymethyl (BOM) group from 14 was achieved by 
exposure to excess EtSH in the presense of BF3 'Et2 0  affording 
the targeted hydroxy methyl ester 5 in 84% yield.
(16) Nicolaou, K. C.; Duggan, M. E.; Hwang, C.-K.; Somers, P. K. J. 
Chem. Soc., Chem. Commun. 1985, 1359. Nicolaou, K. C.; Prasad, C. V. 
C.; Somers, P. K.; Hwang, C.-K. J. Am. Chem. Soc. 1989, 111, 5330,
(17) Nicolaou, K. C.; Duggan, M. E.; Hwang, C.-K. J, Am. Chem. Soc. 
1986,108, 2468. Nicolaou, K. C ; Prasad, C. V. C.; Hwang, C.-K.; Duggan, 
M. E.; Vcale, C. A. J. Am. Chem. Soc. 1989, 111, 5321.
(18) Nicolaou, K. C.; Hwang, C.-K.; Duggan, M. E.; Reddy, B. K.; 
Marron, B. E.; McGarry, D. G. J. Am. Chem. Soc. 1986, 108, 6800. 
Nicolaou, K. C.; Hwang, C.-K.; Marron, B. E.; DeFrees, S. A.; Couladouros, 
E.; Abe, Y,; Carroll, P. J.; Snyder, J. P. J. Am. Chem. Soc. 1990, 112, 
3040.
(19) Nicolaou, K. C.; Duggan, M. E,; Hwang, C.-K. J. Am. Chem, Soc. 
1989, 6676.
(20) Nicolaou, K. C.; Hwang, C.-K.; Duggan, M. E. J. Am. Chem. Soc. 
1989, 11L  6682.
Scheme 3° Synthesis of FGHUK Ring System 5
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‘’ Reagents and conditions; (a) 0.9 equiv of n-BuLi, 3.0 equiv of 
HMPA, THF, -7 8  °C, then add 8 , 30 min, 70%; (b) 0.1 equiv of PPTS, 
MeOH, 25 °C, 90%; (c) 3.0 equiv of AgClO^, 4.0 equiv of K2CO3, 3 
A MS silica, 2,0 equiv of NCS, MeCN, 25 °C, 3 h, 78%; (d) 1.8 equiv 
of PhiSnH, 0,1 equiv of A1BN,1 toluene, 110 °C, 3 h, 92%; (e) Jones1 
reagent, then CH2N2, EtiO, 0 °C, 80%; (f) 1.0 equiv of B ^ ’EtjO, 
CH2Cl2/EtSH (8:1), -40 °C, 30 min, 84%.
Construction of Macrocycles and Attempted Bridging 
Reactions Toward the Brevetoxin B Skeleton
As planned, attempts were then made to reach the complete 
skeleton of brevetoxin B (1) via a bridging reaction, whereby a 
1 2 -membered ring dithionolactone was to serve as a precursor 
to the dioxepane system of the molecule. To this end, the ABC 
ring system 4 (Scheme 4) 21 was coupled with the FGHUK 
segment 5 under the influence of DCC, CSA, and DMAP in 
85% yield, Selective cleavage of the methyl ester from 15 was 
achieved by reaction with lithium ethylthiolate in HMPA to give 
the corresponding carboxylic acid. The /?-methoxybenzyl 
(PMB) group was then removed from the latter compound by 
exposure to DDQ leading to hydroxy acid 16 in 78% overall 
yield, Finally, macrolactonization of 16 using the 2 -pyridine- 
thiol ester method22 furnished dilactone 17 in 70% yield.
Unfortunately, the dithionation of dilactone 17 proved unsuc­
cessful. With a large excess of Lawesson’s reagent, and at high 
temperatures, only a monothionolactone could be obtained (at 
less sterically demanding position). Our inability to introduce 
a second sulfur, adjacent to the methyl substituent (C-13), was 
attributed to steric hindrance provided by the latter group. A
(21) Compound 4 was derived from the corresponding lactone, see: 
Nicolaou, K. C,; Duggan, M. E,; Hwang, C.-K, J. Am. Chem. Soc, 1989, 
111, 6666.
(22) Corey, E. J.; Nicolaou, K. C. J. Am. Chem. Soc. 1974, 96, 5614.
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Scheme 4* Coupling of ABC and FGHUK Ring Systems 4 
and 5 and Failed Bridging Attempts
Scheme Sa A Photolytic Approach to Oxepane Systems
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a Reagents and conditions: (a) 1.1 equiv of 4, 1.0 equiv of 5, 1,2 
equiv of DCC, 0.4 equiv of CSA, 0.4 equiv of DMAP, CH2C12, iO h, 
85%; (b) EtSH, LiH, HMPA, 25 °C, 8  h; (c) 2.0 equiv of DDQ, CH2Cla/ 
H20  (5:1), 25 °C, 3 h, 78% (2 steps); (d) 1.5 equiv of pyr-SS-pyr, 1.5 
equiv of PhjP, toluene, 25 °C, then toluene (0.05 M), reflux» 12 h, 
70%; (e) 10 equiv of Lawesson’s reagent, 6.0 equiv of 1 *1,3,3- 
tetramethylthiourea, xylene, 160 PC, 2 h.
variety of other, new23 and old ,24 Lawesson type reagents failed 
to improve the situation, and the thionation of 17 (and a number 
of related systems) remained an obstacle to further progress 
along this route. We, therefore, decided to abandon the 
simultaneous construction of both oxepane rings via macrocycle 
bridging and to seek a stepwise approach to the dioxepane region 
of brevetoxin B (1).
A Photolytic Approach to Oxepane Systems
Scheme 5 demonstrates, with an example, the adopted concept 
for a new method of forming oxepane systems from acyclic 
precursors. According to this plan a diester, such as 19, is 
converted to its dithiono counterpart (2 0 ) under the standard 
Lawesson conditions, 23,24 and the latter compound is irradiated, 
presumably generating the radical species 2 1 , and thence the 
1,2-dithietane system 22,25 Under the irradiation conditions, 
the latter compound loses sulfur to afford oxepene 23» which is
(23) For several new thionating agents, see: Nicolaou, K. C; McGany, 
D. G.; Somers, P, K.; Kim, B. H.; Ogilvie, W, W.; Yiannikouros, G.; Prasad, 
C. V. C.; Veaie, C. A.; Hark, R. R. J. Am. Chem. Soc. 1990, 112, 6263.
(24) Sheibye, S.; Pederson, E. S.; Lawesson, S. O. Bull. Soc. Chint Belg. 
1978,87 ,229. Lajorie, G.; liPine, F.; Maziaki, L.; Belleau, B. Tetrahedron 
Lett. 1983, 3815.
If*
C U
H Me 
10
OM*
hv
22
0M6
OMe
a Reagents and conditions; (a) 3.0 equiv of Lawesson’s reagent, 3.0 
equiv of 1,1,3,3-tetramethylthiourea, xylene, 160 °C, 2  h, 47%; (b) hvt 
Hanovia 450 W UV lamp, Pyrex filter, toluene, 70 °C, 2 h, 63%; (c) 
2.0 M HC1, 25 °C, 2  h, 80%.
then regioselectively hydrolyzed to oxepanone 24.26 Despite 
the mixture of isomers at C* in oxepene 23, the final product 
24 is obtained, via equilibration under the employed conditions, 
as a single stereoisomer with the two stereocenters flanking the 
carbonyl group firmly established on pseudo-equatorial posi­
tions.
The scope and generality of this method is demonstrated in 
Table 1 which shows several examples of dithionoesters serving 
as precursors to a series of oxepenes and oxepanones. Thion- 
ations were carried out using excess Lawessons’s reagent in 
the presence of 1,1,3,3-tetramethylthiourea at 150—160 °C (50— 
55% yield). The final hydrolytic step was effected eithenmder 
acid conditions (HC1—H2O) or in the presence of fluoride 
(TBAF-THF) (75-95%  yield).
A Reductive Hydroxy Ketone Cyclization Approach to 
Oxepanes
Based on precedent from Olah’s work on the intermolecular 
construction of C ~ 0  bonds using carbonyl and hydroxyl 
components,27 we proceeded to design a new method for the 
synthesis of oxepanes from hydroxy ketones as outlined in 
Scheme 6 . 28 According to this idea, silicon activation of the 
carbonyl oxygen followed by expulsion of the silicon—oxygen 
group by intramolecular attack should lead to oxonium species
41 via the silylated lactol 40 (Scheme 6 ). Subsequent capture 
of the oxonium species 41 by a hydride ion from a suitable 
silane donor, was then expected to form the oxepane system
42 with considerable stereocontrol, depending on the precise 
structure of the substrate.
Exposure of hydroxy ketone 39 to 1.0 equiv of TMS OTf and 
an excess of Et3SiH in CH2CI2 at 0 °C furnished oxepane 42 in
(25) Nicolaou, K, C.; Hwang, C.-K.; Duggan, M. E.; Carroll, P. J. J. 
Am. Chem. Soc. 1987,109, 3801. Nicolaou, K. C.; Hwang, C.-K,; Defrees, 
S.; Stylianides, N. A. J. Am. Chem. Soc. 1988,110,4868. Nicolaou, K. C.; 
DeFreei, S. A.; Hwang, C.-K.; Stylianides, N.; Cairoll, P. J.; Snyder, J. P. 
J. Am. Chem. Soc. 1990, 112, 3029.
(26) Nicolaou, K. C.; Hwang, C.-K.; Nugiel, D. A. Angew. Chem., int. 
Ed. Engl. 1988, 27, 1362.
(27) Sassaman, M, B.; Kotian, K. D.; Prakash, G. K. S.; Olah, G. A. J. 
Org. Chem. 1987, 52, 4314. Sassaman, M. B.; Prakash, G. K. S.; Olah, G. 
A. Tetrahedron Lett. 1988, 44, 3371.
(28) Nicolaou, K, C.; Hwang, C.-K.; Nugiel, D. A. J. Am. Chem. Soc. 
1989, 777, 4136.
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dlthionoe$ter* yield (%) oxepene yield (%) hydfoxyketone1 yield (%)
1
2
e u »H Ri
25: R * Me, Ri * H
28: R * CHjCHzTMS, R,=Me
H
50
50
26: R
29: R
Me, R, « H
CH2CH2TMS, R, -  Me
63
65
27: R « H { tn n r .c is  1:1) 
24: R * Me
80
95
55 62 32 94
HÏ.O.J - Mt H
MeO
OR
H H H
H
MeO
H _ Me H Q ^ n
4
5
33: R * Me, R, *  CH2CH2CH3, Ra 
36: R « CH2CH2TMS(
R, = (CH2)4OBn, R2 « H
Me
MeO
34: R « Me, R, -  CH2CH2CH3, R2 
37 :*«CH aCH2TMS, 
R1*{CH2)4OBn,'flj«H
Me 75
72
MeO
35: R * CH2CH2CH3, R, » Me 75 
38: R -  (CHa)4OBn, R*»H  95
0 3.0 equiv of Lawesson’s reagent, 3.0 equiv of 1,1,3,3-tetraniethylthiourea, xylene, 160 °C, 2 h, bhv , Hanovia 450 W UV lamp, Pyrex filter, 
toluene, 70 °C, 2 h . c For methyl enol ethers; 2.0 M HC1, 25 CC, 2 h. For 2-(trimethy]silyl)ethyl enol ethers: 3.0 equiv of TBAF, TOF, 45 gC, 8 
h.
Scheme 6 fl Mechanistic Rationale for the Silicon-Induced 
Cyclization of Hydroxy Ketones to Oxepanes
Table 2. Reductive Cyclization of Hydroxy Ketones
•nlry hydroxykstona ox«p*n«‘  y)«ld (%)
a
M e / 0  HO Ph
30
TMSOTf
Me"T?OXPh 
TMSO) H
40
1
2
43: X *  H, OH; Y « O 
44: X « Y » O
OHO
T O ' T ’Ph 
H H
42
M# T H 
EtjSIH 41
CD
Me
45
M e*^O^Ph
42 83
83
H n
CD
M*
48 50 (Innmcis 1:1)
“Reagents and conditions: (a) 10 equiv of EtaSiH, 1.0 equiv of 
TMSOTf, CH2CI2, 0 °C, 15 min. 85%.
85% yield. The syn relationship of the protons flanking the 
oxepane oxygen was confirmed by NOE *H NMR studies. As 
Table 2 demonstrates, this reaction proved quite general and 
efficient, accommodating substrates of considerable complexity 
and resemblance to the brevetoxin B (1) dioxepane region. The 
stereoselectivity of the cyclizations varied from ca. 3:1 to ca. 
4:1 at the newly generated fusion» but was always in favor of 
the stereoisomer with the trans arrangement as indicated in the 
structures of Table 2. Whereas the stereochemistries of the 
newly generated ring fusions of compounds 51 and 53 were 
tentatively assigned by comparing lH NMR spectra and Rf 
values with the two isomers of 47, the trans arrangement of 
the major isomer of the latter compound was firmly established 
by an X-ray crystallographic analysis (see ORTEP drawing, 
Figure 1).
Thus, the second required method for oxepane construction 
was developed, and the stepwise construction of the dioxepane 
region of brevetoxin B (1) could now be contemplated.
Construction of Precursors and Attempted Hydroxy 
Ketone Cyclization Toward Brevetoxin B. Encouraged by 
the performance of the two oxepane-forming reactions described 
above, we proceeded to apply them to the brevetoxin B (1) 
problem. First, the BC ring system 67 (Scheme 7) was defined 
as the requisite intermediate onto which the remaining rings 
were to be built starting from ring B and proceeding to the
4
5
32: R » H 
48; R - Me
H 81 {tr*m :ds 4:1) 
Me 90
H H H
MaO
. MeO
6 SO: R » (CH*),OH 81,7S{tmnt:cl$3;\)
BnO^* ÿ BnO.V* ÿ
OH H
BnO
S36 55 (tr»n r,d sZ :))
* 10 equiv of Et3SiH, 1.0 equiv of TMSOTf, CH2CI2, 0 °C, 15 min. 
b Ph2MeSiH was used as the hydride donor.
“right”. Scheme 7 summarizes the construction of this inter­
mediate starting with the previously described ring B system 
54 .29 Thus, replacement of the benzylidene group in 54 with 
benzyl ethers by acid hydrolysis (CSA, MeOH) followed by 
benzylation under standard KH—BnBr conditions furnished 
compound 56 via diol 55 (83% overall yield), Hydroboration
(29) Nicolaou, K. C.; Nugiel, D. A.; Couladouros, E.; Hwang, C.-K. 
Tetrahedron 1990, 46x 4517.
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Figure 1. ORTEP drawing of 47.
Scheme l a Construction of the BC Ring System 67
H Me
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60; R « (£)-CH-CHCH2OH
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BnO
H - M* H .OO^V-sJL^OH
BnO
H H 
66
I
H Me H
B n O 'f ^ 'T 'oH H H 
66
C02Et
a Reagents and conditions: (a) 0.2 equiv of CS A, MeOH, 0 °C, 1 h, 
92%; (b) 2.5 equiv of KH, 2.7 equiv of BnBr, 45 °C, THF, I h, 90%; 
(c) 1.5 equiv of 9-BBN, THF, 25 °C, 1.5 h, then 10 equiv of 3 N 
NaOH, 2 0  equiv of 30% H2O2, 0 °C, 1 h, 94%; (d) 1.5 equiv of (COCl)a, 
2.0 equiv of DMSO, 5.0 equiv of Et3Nt CH2CI2, -78 °C, 1 h, 96%; (e) 
1.2 equiv of PhsP^CHCOiMe, benzene, 50 °C, 1 h, 90%; (f) 2.2 equiv 
of DIBALH, CH2Cl2l -78  °C, 30 min, 96%; (g) 0.25 equiv of (-)* 
diethyl tartrate, 0.2 equiv of Ti(0 -/-Pr)4, 1.5 equiv of f-BuOOH, CH2CI2, 
-25  °C, 14 h, 92%; (h) 3.0 equiv of SO3*pyridine, 5.0 equiv of EtsN, 
CH2C12:DMS0 (4:1), 0 eC, 4 h, 94%; (i) 1.1 equiv of PhjP-CMeCC^Et, 
0.1 equiv of PhC02H, benzene, 25 °C, 30 min, 90%; (j) 1*5 equiv of 
TBAF, THF, 25 °C, 30 min, 96%; (k) 0.8 equiv of PPTS, CH2C12, 25 
°C, 13 h, 97%; (1) H2, 10% Pd/C, EtOAc, 25 °C, 48 h, 100%; (m) 5.0 
equiv of TMSCH2CH2OH, 0,15 equiv of KH, THF, 25 eC, 15 min, 
91%.
of the terminal olefin in 56 with 9-BBN followed by basic 
hydrogen peroxide workup gave primary alcohol 57 (94% yield) 
which was then oxidized under Swem conditions to the aldehyde 
58 (96%). Condensation of the latter compound with the 
appropriate phosphorane afforded the a^5-unsaturated ester 59 
(90%) whose DIBALH reduction led to allylic alcohol 60 (96% 
yield). Sharpless AE of 60 using (-)-diethyl tartrate as the 
chiral auxiliary gave epoxide 61 (92% yield), oxidation of which 
with S(>3 'pyr led to aldehyde 62 in 94% yield. Olefination of 
62 with Ph3p*“CMeC0 2 Et under the influence of PhCO^H as 
catalyst gave compound 63, which upon exposure to fluoride 
ion suffered desilylation furnishing hydroxy epoxide 64 in 8 6 % 
overall yield. Exposure of 64 to mild acid conditions (PPTS, 
CH2CI2) induced regio- and stereospecific ring closure affording 
bicyclic ether 65 in 97% yield. Hydrogenation of the latter 
compound followed by /ra/w-esterification with TMSCH2CH2-
Scheme 8 fl Construction of the Advanced Dioxepane Model
73
B I 0
h
69: X *  O
70; X « S
TMS TMS
BnO
73
BnO" 4 " ^  * "O 
H H H
72
“ Reagents and conditions: (a) 1.5 equiv of DCC, 0.3 equiv of CSA, 
0.3 equiv of DMAP, 1.0 equiv of 6 8 , CH2C1:, 10 h, 85%; (b) 3.0 equiv 
of Lawesson's reagent, 3.0 equiv of 1,1,3,3-tetramethylthiourea, xylene, 
180 °C, 2 h, 58%; (h) bv, Hanovia UV lamp, 450 W, Pyrex filter, 
toluene, 70 °C, 20 h, 72%; (d) 1 . 2  equiv of TBAF, THF, 45 °C, 8  h, 
8 8 %; (e) 10 equiv of Ph2MeSiH, 1,0 equiv of TMSOTf, CH2C12, 0 °C, 
2 0  min, 62% (6 : 1  mixture of trans:cis isomers).
OH and KH gave hydroxy ester 67 in 91% yield as a 1:1 mixture 
of diastereoisomers.
Coupling of 67 with carboxylic acid 6 8 30 (Schcme 8 ) via 
esterification (DCC, DMAP, CSA, 85% yield), followed by 
thionation using Lawesson's reagent as described above for the 
model diesters, gave rise to dithionoester 70 via 69 (58% yield). 
Photolysis of 70 in toluene at 70 °C for 20 h led to oxepene 
system 71 in 72% yield. Exposure of 71 to TBAF at 45 °C in 
THF furnished oxepanone 72 as a single stereoisomer and in 
8 8 % yield. Finally, reductive cyclization of 72 using TMSOTf 
and Ph2MeSiH resulted in the desired pentacyclic system 73 
containing the BCDE framework of brevetoxin B (1) (62% yield, 
ca. 6:1 ratio of transxis isomers). The trans stereochemistry 
of the newly generated DE ring fusion in the major product 73 
was assigned on the basis of the coupling constant Ja>* =  7.7 
Hz, which is almost identical to the corresponding value for 
brevetoxin B (1) (7.73 Hz). Encouraged by the success of these 
advanced model studies, we proceeded to implement the latest 
strategy with two real systems for brevetoxin B (1).
Ring F, as intermediate 83, was synthesized in a straight­
forward manner from the previously reported compound 7429 
as detailed in Scheme 9. Carboxylic acid 83 was then coupled 
with alcohol 67 via ester bond formation as shown in Scheme 
10 to afford diester 84 in 8 8 % yield. The latter compound was 
elaborated to hydroxy ketone 87 via intermediates 85 and 8 6  
according to the general methods described above [thionation 
(56%), photolytic ring closure (64%), and hydrolysis (91%)]. 
Treatment of hydroxy ketone 87 with TMSOTf and excess 
Ph2MeSiH under the standard cyclization conditions led to a 
single compound in 46% yield. The latter compound, originally 
thought to be the desired product 8 8 , was taken through a series 
of reactions toward what was projected to be a more advanced 
intermediate (90a) for brevetoxin B. (1) as shown in Scheme 
1 1 . Finally, however, an X-ray crystallographic analysis of the 
crystalline p-nitrobenzoate derivative 91 (see ORTEP drawing, 
Figure 2) revealed a rearranged structure which was traced back
(30) Compound 68 was synthesized from 1,4-butanediol in 12 steps, 
see: Duggan, M. E. Ph.D. Dissertation, University of Pennsylvania, 1987.
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Scheme 9* Construction of F Ring Intermediate 83
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OBn
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01
“ Reagents and conditions: (a) 1.2 equiv of KH* 1.3 equiv of BnBr, 
THF, 45 °C, 1 h, 90%; (b) 1.5 equiv of 9-BBN, THF, 25 °C, 1 h, then 
7.5 equiv of 3 N NaOH, 10 equiv of 30% H2O2, 0 °C, 1 h, 93%; (c) 
1.2 equiv of KH, 1,3 equiv of BnBr, THF, 45 °C, 1 h, 88%; (d) 0.2 
equiv of CSA, MeOH, 0 °C, 1 h, 89%; (e) 2.5 equiv of TBSC1, 3.0 
equiv of imidazole, DMF, 45 °C, 14 h, 95%; (0 1.5 equiv of (COCl)2, 
2.0 equiv of DMSO, 5.0 equiv of Et3N, CH2C12, -7 8  °C, 1 h; (g) 1.1 
equiv of PhaP-CHCOzMe, benzene, 50 °C, 12 h, 81% (2 steps); (h) 
H2, 10% Pd/C, EtOAc, 6 h, 25 °C, 100%; (i) 1.6 equiv of LiOH, THF: 
M e0H:H20  (1:1:1), 55 °C, 3 h, 94%.
to the cyclization reaction of compound 87 (Scheme 10). Thus, 
it became clear that the reductive ring closure of the latter 
compound (87) was accompanied by a drastic skeletal re­
arrangement giving compound 89, rather than the expected 8 8  
(Scheme 1 0 ). Two alternative and speculative mechanisms for 
this novel skeletal rearrangement are presented in Scheme 12. 
A common underlying driving force to both mechanisms is the 
severe 1,3-diaxial interaction of the two methyl groups on ring 
F, which is thought to be facilitating the rupture of the latter 
ring. The two pathways differ in which 0 - 0  bond breaks, and 
which methyl group contributes to stabilization of the incipient 
positive charge on one of the reactive species of each sequence 
(structures 92 and 92a, Scheme 12).
Since FGHUK intermediate 5 (Scheme 4) was available from 
the previous studies of the bridging approach, a final attempt 
to secure the BCDEFGHUK framework of brevetoxin B (1) 
was made according to Scheme 13, Thus, coupling of alcohol 
67 with the carboxylic acid 94, derived from 5 in the presence 
of DCC, DMAP, and CSA, furnished ester 95 in 85% yield, 
Thionation of the ester 95 using Lawesson's reagent and 1,1,3,3- 
tetramethylurea as described above afforded the desired dithio- 
noester 96 (20% yield). Photolytically-induced ring closure of 
96 furnished oxepene 97 (63%) which underwent selective 
hydrolysis to the hydroxy ketone 98t obtained as a single isomer, 
upon exposure to TBAF in THF (70%). Attempts to cyclize 
hydroxy ketone 98, however, were unsuccessful, and under no 
circumstances could the expected product 99 be detected. It 
was of interest to observe that the main product in this, rather 
sluggish, reaction was the reduced, open-chain diol, correspond­
ing to 98, and that no rearranged product corresponding to 
compound 89 (Scheme 10) was detected.
Conclusion
«
A number of convergent strategies toward brevetoxin B (1) 
were considered and pursued in this initial phase of the 
brevetoxin B project. The originally favored approach enjoying 
optimum convergency involved generation, coupling, and 
elaboration of three key intermediates containing the ABC, FG, 
and UK frameworks, respectively (e.g., 4, 7, and 8 , Scheme 2 ). 
The construction of all three tetrahydropyran-containing key 
segments proceeded well, and so did the Wittig coupling of the
Scheme 10* Coupling of BC and F Ring Systems 67 and 83 
and Failed Hydroxy Ketone Cyclization Attempts
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H ^OBn
BnO
BnO
BnO
08n
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a Reagents and Conditions: (a) 1.5 equiv of DCC, 0,3 equiv of CSA, 
0.3 equiv of DMAP, CH2O 2, 10 h, 88%; (b) 3.0 equiv of Lawesson’s 
reagent, 3.0 equiv of 1,1,3,3-tetramethylthiourea, xylene, 160 °Ct 2 h, 
56%; (c) hv% 450 W Hanovia lamp, Pyrex filter, benzene 25 °C, 2 h, 
64%; (d) 3.0 equiv of TBAF, THF, 50 °C, 10 h, 91%; (e) 3.5 equiv of 
PhjMeSiH, 1,5 equiv of TMSOTf, CH2C12, 0 °C, 40 min, 46%.
FG and UK segments (7 and 8 ) and the cyclization to install 
the oxocene ring system, leading smoothly to the FGHUK ring 
framework (5, Scheme 3). Coupling of the latter system with 
the ABC ring framework (4) via esterification followed by 
macrolactonization led to potential precursors to the complete 
framework of brevetoxin B (1). All attempts, however, to 
thionate and subsequently bridge the 1 2 -membered macrocycle, 
in order to form the last remaining bond required for completion 
of the brevetoxin B skeleton, were unsuccessful, forcing 
consideration of a revised strategy in which a stepwise approach 
to the dioxepane region of the molecule was adopted. To this 
end, two new methods for the construction of oxepane ring 
systems were invented and explored (Schemes 5 and 6 ). While 
both methods proved quite general and successful in model 
systems, only the first one, involving photolytically-induced ring 
closure of dithionoesters, proved applicable to the brevetoxin 
B (1) problem. The second approach, utilizing reductive 
cyclization of hydroxy ketones, led to novel skeletal rearrange­
ments or unproductive reduction of the carbonyl function when 
applied to real systems (Schemes 10 and 13),
Despite the failure of these first generation approaches to 
brevetoxin B (1) a great deal of new chemistry was developed, 
including new reactions for the construction of cyclic ethers 
with 6 -, 7-, and 8 -membered rings. Furthermore, the informa-
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Scheme 11a Elaboration of Rearrangement Product 89
Ma H
90
Mr*, M#0*J
g-n
Me H J \
a Reagents and conditions: (a) H2, Pd(OH)2, Ac0Et:Me0H (2:1), 
25 °C, 14 h, 95%; (b) 3.0 equiv of Me2C(0M e)2, 0.1 equiv of PPTS, 
acetone, 25 °C, 14 h, 91%; (c) Ac0H:H20  (2:1), 80 eC, 2.5 h, 88%; 
(d) 1.2 equiv of PivCl, pyridine, 0 °C, 30 min, 96%; (e) 1.3 equiv of 
TBSCI, 1.5 equiv of imidazole, DMF, 55 °C, 4 h, 94%; (f) 2.2 equiv 
of DIBALH, “ 78 °C, 30 min, 97%; (g) 1.5 equiv of (COCfe, 2.0 equiv 
of DMSO, 5.0 equiv of Et3N, CH2C12, -7 8  °C, 1 h, 96%; (h) 1.2 equiv 
of Fh3P—CMeC02Et, benzene, 50 °C, 1 h, 87%; (i) 2,2 equiv of 
DIBALH, -7 8  °C, 30 min, 97%; (j) 1.2 equiv of m-CPBA, CH2C12, 0 
°C, 30 min, 94%; (k) 4.0 equiv of S 0 3*pyr, 5.0 equiy of Et3N, CH2C12: 
DMSO (4:1), 0 °C, 3.5 h, 92%; (1) 1.5 equiv of P h ^ M e B r ,  1.3 equiv 
of NaHMDS, THF, 0 °C, 1 h, 89%; (m) 1.5 equiv of TBAF, THF, 25 
°C, 30 min, 96%; (n) 1.1 equiv of p-nitrobenzpyl chloride, 2.0 equiv 
of DMAP, 25 °C, 20 min, 86%.
011
HI
C2#
Figure 2. ORTEP drawing of 91.
tion gathered was of crucial importance to designing the next 
generation strategies which are the subject of the following 
articles. 12,13,31
Experim ental Section
General Techniques. All reactions were carried out under an argon 
atmosphere in dry, freshly distilled solvents under anhydrous conditions, 
unless otherwise noted. Tetrahydrofuran (THF) and diethyl ether (Et20 ) 
were distilled from sodium/benzophenone, dichloromethane (CH2C12) 
and toluene from calcium hydride, and benzene from potassium. Yields 
refer to chromatographic ally and spectroscopically (*H NMR) homo­
geneous materials, unless otherwise stated. Reagents were purchased 
at highest commercial quality and used without further purification 
unless otherwise stated. Reactions were monitored by thin-layer
(31) For preliminary communications on the total synthesis of brevetoxin 
B, see: Nicolaou, K. C.; Theodorakis, E. A.; Rutjes, F. P. J. T.; Tiebes, J.; 
Sato, M.; Untersteller, E.; Xiao, X.-Y. J. Am . Chem, Soc. 1995,117 , 1171, 
Nicolaou, K. C.; Rutjes, F. P. J. T.; Theodorakis, E. A,; Tiebes, J.; Sato, 
M;; Untersteller, E. J, Am. Chem. Soc, 1995, 777, 1173.
Scheme 12. Plausible Mechanisms for the TMSOTf/ 
PhiMeSiH-induced Conversion of 87 to 89
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chromatography carried out on 0.25 mm E. Merck silica gel plates (60F- 
254) using UV light as visualizing agent and 7% ethanolic phospho- 
molybdic acid orp-anisaldehyde solution and heat as developing agents. 
E. Merck silica gel (60, particle size 0.040—0.063 mm) was used for 
flash chromatography. Preparative thin-layer chromatography separa­
tions were carried out on 0.25 or 0.50 mm E, Merck silica gel plates 
(60F-254). NMR spectra were recorded on Brucker AM-500 or WM- 
250 instruments and calibrated using residual undeuterated solvent as 
an internal reference. The following abréviations were used to explain 
the multiplicities: s — singlet; d — doublet, t — triplet, q =  quartet, m 
— multiplet, b — broad. IR spectra were recorded on a Perkin-Elmer 
Model 781 spectrometer. Optical rotations were recorded on a Perkin- 
Elmer 241 polarimeter. High resolution mass spectra (HRMS) were 
recorded on a VG 7070 HS mass spectrometer under chemical 
ionization (Cl) conditions or on a VG ZAB-ZSE mass spectrometer 
under fast atom bombardment (FAB) conditions, Microanalyses were 
performed by Robertson Laboratories, Madison, NJ. Melting points 
(mp) are uncorrected and were recorded on a Thomas Hoover Unimelt 
capillary melting point apparatus.
Dithioketal 11. n-Butyllithium (0.60 mL, 1.5 M solution in hexane, 
0.9 mmol) was added dropwise to a stirred mixture of phosphonium 
salt 7 (960 mg, 1.0 mmol) and HMPA (0.52 mL, 3.0 mmol) in THF (5 
mL) at —78 °C. The mixture was stirred for 10 min at -7 8  °C and 
for 10 min at 0 °C before the aldehyde 8 (587 mg, 0.80 mmol) in THF 
(3 mL) was added dropwise at —78 °C. The mixture was allowed to 
warm to 25 CC, quenched with aqueous saturated ammonium chloride
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Scheme 13° Coupling of BC and FGHUK Ring Systems 67 
and 94 and Failed Hydroxy Ketone Cyclization Attempts
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"Reagents and conditions: (a) 1.5 equiv of TBSCI, 2.0 equiv of 
imidazole, DMF, 50 °C, 5 h; (b) 2.0 equiv of LiOH, DME/H20  4:1, 
25 °C, 1 h, 81% (2 steps); (c) 2.0 equiv of 67, 1.0 equiv of 94, 2.5 
equiv of DCC, 2.0 equiv of DMAP, 1.0 equiv of CSA, THF, 10 h, 
85%; (d) 3.0 equiv of Lawesson’s reagent, 3.0 equiv of 1,1,3,3- 
tetramethylthiourea, xylene, 185 °C, 2 h, 20%; (e) /tv, Hanovia 450 W 
lamp, Pyrex filter, benzene, 70 °C, 2 h, 63%; (f) 3.5 equiv of TBAF, 
THF, 45 QC, 10 h; then 1.1 equiv of TPSC1, 1.5 equiv of imidazole, 
DMF, 2 h, 25 °C, 70%; (g) 10 equiv of Ph3MeSiH, 1.5 equiv of 
TMSOTf, CH2CI2, 0 °C, 1 h.
(5 mL) and diluted with ether (50 mL). The organic phase was 
separated, washed with aqueous saturated ammonium chloride ( 2 x 5  
mL), and brine (5 mL), dried (MgSO^), concentrated, and chromato­
graphed (silica, 20% ether in petroleum ether) to give the coupling 
product 11 (926 mg, 0.70 mmol, 70%). 11: colorless oil; R/ =  0.33 
(silica, 2 0 %  ether in petroleum ether); [ cc] 22d  +16,6 ( c  2.8, CH2CI2); 
IR (film) 3100,3080, 3041,2971, 2935, 2900, 2862, 1460,1385, 
1262, 1123, 1050, 892, 845, 746, 708, 688, 621 cm”1; ‘H NMR (250 
MHz, CDCI3) 6 7.69-7.25 (m, 20 H, ArH), 5.90 (m, 1 H, ~CH), 5.69 
(t, J  =  U .5 Hz, 1 H, -C H ), 4.88 (d, /  =  8.5 Hz, 1 H, CtfHPh), 4.77 
(d, J  =  11.5 Hz, 1 H, CflHPh), 4.73 (d, J  =  8.5 Hz, 1 H, CtfHPh),
4.62 (s, 2 H, OCH2O), 4.57 (d, J  -  11.5 Hz, 1 H, CtfHPh), 4.31 (d, J  
-  8.0 Hz, 1 H, O CffCH -), 4.15—3.54 (m, 11 H, OCH), 3.23 (bd, J  «
12.0 Hz, 1 H, OCH), 3.02—2.98 (m, 1 H, OCH), 2.79-1.50 (m, 20 H,
SCH2, CH), 1.33-1.29 (4 x s, 4 x 3 H, CH3), 1.19 (m, 6  H, 2  x 
CH2C//3), 1.08 (s, 9 H, i-Bu), 0.92 (s, 9 H, r-Bu), 0.18 (s, 9 H, Si(CH3)3), 
0.06 (s, 6  H, Si(CH3)2); HRMS (FAB), calcd for C74HM3O 11SÌ3O2 (M 
+  H+) 1325.7032, found 1325.6946.
Alcohol 6 . Pyridinium /Moluenesulfonate (7.5 mg, 0.03 mmol) was 
added to a solution of dithioketal 11 (396 mg, 0.30 mmol) in MeOH 
(5 mL). The reaction mixture was stirred at 25 °C for 30 min, diluted 
with ether (50 mL), washed with H2O ( 2 x 1 0  mL) and brine (5 mL), 
dried (MgSO*), concentrated, and chromatographed (silica, 40—80% 
ether in petroleum ether) to give the alcohol 6  (270 mg, 72%) and 
dihydroxy compound (56 mg, 18%). Selective monosilylation (1.1 
equiv of fóri-butyldimethylsilyl chloride, 1.2 equiv of imidazole, DMF, 
25 °C) of this diol afforded hydroxy dithioketal 6  quantitatively, raising 
the total yield of this product to 338 mg (0.27 mmol, 90%). 6 : colorless 
oil; Rf =  0.40 (silica, 40% ether in petroleum ether); [a]22D +44.2 (c
2 .2 , CH2CI2); IR (film) vmx 3500, 3080,3038,2960,2935, 2900,2858, 
1465,1382,1260,1110,1050, 842,781,741,702,681 cm -'; lHNMR 
(250 MHz, CDC13) 6 7.68-7.20 (m, 20 H, ArH), 5,95 (m, 1 H, -C H ), 
5.80 (t, J  =  11.5 Hz, 1 H, —CH), 4.86 (d, J  «  8.0 Hz, 1 H, CffHPh),
4.73 (d, J  =  8.5 Hz, 1 H, CtfHPh), 4,71 (d, /  =  12.0 Hz, 1 H, CtfHPh),
4.62 (s, 2 H, 0CH20), 4.54 (d, /  -  12.0 Hz, 1 H, CtfHPh), 4.34 (d, J  
=  8.5 Hz, 1 H, O C//CH -), 4,18-3.52 (m, 11 H, OCH), 4.03-3.97 
(m, 1 H, OCH), 3.26 (bd, J  =  12.0 Hz, 1 H, OCH), 2.66-1.50 (m, 24 
H, SCH2, CH), 1.31-1.17 (m, 18 H, 4 x CH3, 2 x SCH2Ctf3), 1.08 
(s, 9 H, /-Bu), 0.91 (s, 9 H, /-Bu), 0.05 (s, 6 H, Si(CH3)2); HRMS 
(FAB), calcd for C71H105O11S2SÌ2 (M +  H+) 1253.6637, found 
1253.6709.
Oxocene 12. A heterogeneous mixture of the hydroxy dithioketal
6 (200 mg, 0.16 mmol), potassium carbonate (88 mg, 0.64 mmol), silica 
(500 mg), and powdered 3 À molecular sieves (500 mg) in CH3CN 
(10 mL) at 25 °C was treated with anhydrous silver perchlorate (99.0 
mg, 0.48 mmol). After stirring for 30 min, N-chlorosuccinimide (43 
mg, 0.32 mmol) was added followed by vigorous stirring for 4 h. The 
reaction was quenched with triethylamine (0.5 mL), diluted with ether, 
and filtered through Celite. The mixture was concentrated and 
chromatographed (silica, 20% ether in petroleum ether) to give the 
oxocene 12 (149 mg, 0.13 mmol, 78%). 12: colorless oil; R/ -  0.48 
(silica, 30% ether in petroleum ether); (a]22o +69.0 (c 1.0, CH2CI2); 
IR (film) vmM 3084, 3049, 2987, 2945, 2898, 2878, 1472, 1389,1276,
1123, 1050, 975, 845, 785, 749, 711, 624 cm“ 1; 5H NMR (250 MHz, 
CDCI3) ò 7*68—7,24 (m, 20 H, ArH), 5.97-5.84 (m, 2 H, C H -C H ), 
4.86 (d, J  =  7.0 Hz, 1 H, O/HPh), 4.78 (d, J  =  12.5 Hz, 1 H, CHHPh),
4.73 (d, J  *  7.0 Hz, 1 H, CHHPh), 4.72 (dd, J  =  12.0 Hz, 4.5 Hz, I
H, CHOCSEt), 4.62 (s, 2 H, OCH2O), 4.54 (d, J  =  12.5 Hz, 1 H, 
CtfHPh), 4.18-3.53 (m, 10 H, OCH), 3.25 (bd, J  «  12,5 Hz, 1 H, 
OCH), 3.00—2.95 (m, 1 H, OCH), 2.60-1.47 (m, 18 H, SCH2, CH),
I.31-1.17 (m, 15 H, 4 x CH3, SCHjCtfj), 1.07 (s, 9 H, f-Bu), 0.92 (s,
9 H, r-Bu), 0.04 (s, 3 H, SiCH3), 0.02 (s, 3 H, S1CH3).
Oxocene 13, A mixture of oxocene 12 (130 mg, 0.11 mmol), 
triphenyltin hydride (70 mg, 0.2 mmol) and 2,2'-azobis(isobutyronitrile) 
(8 mg) in toluene (2 mL) was heated at 110 °C for 3 h. Concentration 
and flash chromatography (silica, 20% ether in petroleum ether) afforded 
oxocene 13 (114 mg, 0.10 mmol, 92%). 13: colorless oil; /?/=  0.45 
(30% ether in petroleum ether); [a]a D +55.0 (c 1.5, CH2C12); IR (film) 
ita* 3080, 3041, 2996, 2940, 2895, 2861, 1471, 1390, 1271, 1110, 
1050, 841, 781, 642,610 cm"1; 'H NMR (250 MHz, CDCU) à 7 .7 0 -
7.22 (m, 20 H, ArH), 5.80 (m, 2 H, CH -CH ), 4.84 (d, J  =  7.0 Hz, 1
H, CffHPh), 4.78 (d, J  «  12.5 Hz, 1 H, CtfHPh), 4.72 (d, J  =  7.0 Hz; 
1 H, CHHPh), 4.62 (s, 2 H, OCH2O), 4.52 (d, J  =  12.5 Hz, 1 H, 
CHHPh), 4.20-3.22 (m, 13 H, OCH), 2.89-2,85 (m, 1 H, OCH), 
2.52-1.35 (m, 16 H, CH)f 1.29 (s, 3 H, CH3), 1.28 (s, 3 H, CH3), 1.25 
(s, 3 H, CH3), 1.20 (s, 3 H, CH3), 1.09 (s, 9 H, i-Bu), 0,94 (s, 9 H, 
r-Bu), 0.06 (s, 6 H, Si(CH3)2); HRMS (FAB), calcd for CéT^OnSi* 
(M +  H+) 1131.6413, found 1131.6599.
Methyl Ester 14. Jones’ reagent (ca. 20 drops, prepared from 
chromium trioxide (11.1 g), sulfuric acid (9.7 mL), and H20  (25 mL)) 
was added dropwise to a stirred solution of oxocene 13 (114 mg, 0.10 
mmol) in acetone (1 mL) at 0 °C. After completion of the reaction, 
isopropyl alcohol (0.5 mL) was added at 0 °C, followed by ether (100 
mL). The solution was washed with H2O (2 x 10 mL) and brine (2 x
10 mL), dried (MgSOu), and concentrated. The resulting crude 
carboxylic acid was dissolved in ether (2 mL) and treated with excess
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diazomethane (ether solution) at 0 QC to afford, after flash chroma­
tography (silica, 40% ether in petroleum ether), methyl ester 14 (85 
mg, 0.080 mmol, 80%). 14: colorless oil; = 0.50 (silica, 40% ether 
in petroleum ether); [a)nD +55.7 (c 2.3, CH2Ci2); IR (film) 3095, 
3078, 3017, 2980, 2880, 2858, 1733, 1413, 1382, 1268, 1112, 1051, 
825, 740, 705, 682, 613 cm"1; lH NMR (250 MHz, CDC13) <5 7.70-
7.22 (m, 20 H, ArH), 5.80 (m, 2 H, CH-CH), 4.86 (d, J  = 7.5 Hz, 1 
H, CffHPh), 4.78 (d, J  =  12.0 Hz, 1 H, CtfHPh), 4.72 (d, J  =  7.5 Hz,
1 H, CHHPh), 4.62 (s, 2 H, 0CH20), 4.52 (d, /  = 12.Q Hz, 1 H, 
CfíHPh), 4.20-3.20 (m, 11 H, OCH), 3.66 (s, 3 H, C02CH3), 2.90-
2.85 (m, 1 H, OCH), 2 .5 6 -1 .4 0  (m, 14 H, CH),  1.30 (s, 6  H, 2 x 
CH3), 1.28 (s, 3 H, CH3), 1.16 (s, 3 H, CH3), 1.08 (s, 9 H, /-Bu); HRMS 
(FAB), calcd for C62HwOi2SiNa (M +  Na+) 1067.5317, found 
1067.5339. Anal Calcd for CgjHsoOjiSi: C, 71,23; H, 7.71. Found: 
C, 71.13; H, 8.10,
Alcohol 5. Methyl ester 14 (104 mg, 0.10 mmol) was dissolved in 
CH2C12 (2 mL) and ethanethiol (0.25 mL) and cooled to -40 °C. Boron 
trifluoride etherate (0.10 mL of a 1.0 M solution in CH2CI2, 0.10 mmol) 
was added and stirring was continued for 30 min at —40 °C before 
quenching with triethylamine (0.2 mL). The reaction mixture was 
poured into aqueous saturated sodium bicarbonate (5 mL) and ether 
(10 mL). The organic layer was washed with H2O (5 mL), brine (5 
mL), dried (MgSO*), concentrated and chromatographed (silica, 50% 
ether in petroleum ether) to afford alcohol 5 (78 mg, 0.084 mmol, 84%). 
5: colorless oil; R f — 0.33 (silica, 80% ether in petroleum ether); [cl]2^  
+52.4 (c 1 .6 , CH2CI2); IR (film) 3430, 3080, 3061, 3041, 2960, 
2939,2896, 2882,1735, 1442,1382,1221,1110,1062, 831,745,707, 
618 cm"*; JH NMR (250 MHz, C D C I 3)  6  7,68-7.24 (m, 20  H, ArH), 
5.79 (m, 2 H, CH-CH), 4.78 (d, J  «  12,5 Hz, 1 H, CtfHPh), 4.51 (d, 
J  =  12.5 Hz, 1 H, CffHPh), 4.18-3.22 (m, 11 H, OCH), 3.70 (s, 3 H, 
C02CH3), 2.87 (m, 1 H, OCH), 2.50-1.40 (m, 14 H, CH), 1.30 (s, 3
H, CH3), 1.27 (s, 3 H, CH3), 1.25 (s, 3 H, CH3), 1.17 (s, 3 H, CH3),
I.08 (s, 9 H, /-Bu); HRMS (FAB), calcd for C52H73O11SÍ (M 4- H+) 
925,4922. found 925.4850.
Dithionoester 20. A stirred solution of diester 1926 (186 mg, 0 . 6 8  
mmol), Lawesson's reagent (0.72 g, 2.1 mmol), and 1,1,3,3-tetrameth- 
ylthiourea (310 mg, 2.1 mmol) in xylene (2.5 mL) was heated at 160 
6C in a sealed tube. After 2 h, the reaction mixture was concentrated 
and subjected to flash chromatography (silica, 10—30% ether in 
petroleum ether) to give the dithionoester 20 (52 mg) and a mixture of 
monothionated product and unreacted starting material. This mixture 
was recycled twice to give additional product (total 97 mg, 0.32 mmol, 
47%) as a mixture of diastereoisomers. 20: colorless oil; fy = 0.68 
(silica, 20% ether in petroleum ether); IR (film) Vm« 2960, 2870,1460, 
1440, 1190, 1100, 1030, 760 cm“1; 'H NMR (250 MHz, CDCI3) <5
5.17 (m, 1 H, C(S)OCH), 4.07, 4.04 (s, 3 H, OCH3), 3.88 (m, 1 H, 
OCH), 3.48-3.02 (m, 3 H, OCH), 2.68 (m, 2 H, OCH), 2.32-1.34 
(m, 8  H, CH), 1.19 (m, 3 H, CH3), 0.93 (m, 3 H, CH3); HRMS (FAB), 
calcd for Ci4H250 3S2 (M +  H+) 305.1245, found 305.1281.
Oxepene 23, A solution of dithionoester 20 ( 8 6  mg, 0.28 mmol) in 
benzene (23 mL) was deoxygenated with argon for 30 min and then 
irradiated with a Hanovia lamp (450 W) using a Pyrex filter (Am** > 
285 nm), After 2 h, the reaction mixture was concentrated and 
subjected to flash chromatography (silica, 10-"30% ether in petroleum 
ether) to give the oxepene 23 (42 mg, 0.175 mmol, 63%) as a mixture 
of diastereoisomers. 23: colorless oil; Rf — 0,48 (silica, 30% ether in 
petroleum ether); IR (film) 2940,1200,1110 e n r1; >H NMR (250 
MHz, CDCb) <5 3.83 (ra, 1 H, OCH)t 3.47, 3.40 (s, 3 H, OCH3), 3.39- 
2.91 (m, 3 H, OCH), 2.53 (m, 1 H, CH), 2.21-1.37 (m> 10 H, CH),
1.22, 1.13 (d, / =  7.4 Hz, 3 H, CH3), 0.88 (m, 3 H, CH3); HRMS (Cl), 
calcd for CiíH240 3 (M+) 240.1725, found 240.1718.
Oxepanone 24. A solution of oxepene 23 (107 mg, 0.33 mmol) in 
THF (1.5 mL) was treated with aqueous hydrochloric acid (0.2 mL, 
2.0 M in H20) at 25 °C. After 2.5 h, the reaction mixture was diluted 
with ether (5 mL), washed with saturated aqueous sodium bicarbonate 
(4 mL), dried (MgSO*), and concentrated. The solvent was evaporated 
and the residue subjected to flash chromatography (silica, 30-^50% 
ether in petroleum ether) to give oxepanone 24 (60 mg, 0.26 mmol, 
80%) as a single diastereoisomer. 24: colorless oil; /?/= 0.17 (silica, 
30% ether in petroleum ether); [a]22o —153.6 (c 0.25, CH2C12); ER 
(film) 2940, 2880, 1720, 1465, 1385, 1130, 1100, 960 cm“1; ‘H 
NMR (500 MHz, CDC13) Ó 3.88 (dd, J =  9.4, 3,6 Hz, 1 H, C(O)-
CHO), 3.82 (dd, /  -  9.4, 3.6 Hz, 1 H, OCH), 3.59 (m. 1 H, OCH), 
3.34 (m, 1 H, OCH), 2.92 (m, 1 H, OCH), 2.69 (m, 1 H, Ctf(CH3)C- 
(O)), 2.04 (m, 1 H, CH), 1.94 (m, 1 H, CH), 1.73-1.42 (m, 8  H, CH), 
J.35 (d, J «  7.4 Hz, 3 H, CH3), 0.90 ( U J -  7.3 Hz, 3 H, CH2); 13C 
NMR (125 MHz, CDCl3) 6 217.60, 86.95, 80.20, 80.47, 67.52, 38.79, 
37.72, 35.18, 30.92,25.67, 18.65, 16.33, 13.70; HRMS (Cl), calcd for 
Ci3H220 3 (M+) 226.1569, found 226.1567.
Dithionoester 30. Dithionoester 30 was prepared following the same 
procedure as for 20 from the corresponding diester36 (265 mg, 0.38 
mmol). Flash chromatography (silica, 10—30% ether in petroleum 
ether) gave dithionoester 30 (153 mg, 0.22 mmol, 55%). 30: colorless 
oil; Rf = 0.71 (silica, 20% ether in petroleum ether); IR (film) vraw 
2970, 2860, 1470, 1430, 1250, 1170, 1100, 845, 740, 705, 615 cm-*1; 
lH NMR (250 MHz, CDCI3) 6 7.65-7.35 (m, 10 H, ArH), 5,24 (m, 1
H, CHO(S)C), 4.52 (m, 2 H, CH20(S)C), 3.91 (m, 1 H, OCH), 3,72 
(m, 1 H, OCH), 3,47-3.10 (m, 5 H, OCH), 2.75 (m, 3 H, CHaC(S)), 
2.33 (m, 1 H, CH2C(S))t 2.08-1.22 (m, 12 H, CH), 1.07 (m, 2 H, 
CH2Si), 1.01 (s, 9 H, f-Bu), 0.02 (s, 9 H, Si(CH3)3); HRMS (FAB), 
calcd for C37H360 5 S2Si2Na (M + Na+) 723.3005, found 723.3110.
Oxepene 31. Oxepene 31 was prepared following the same 
procedure as for 23 above from dithionoester 30 (87 mg, 0,12 mmol). 
Flash chromatography (silica, 10—'30% ether in petroleum ether) gave 
oxepene 31 (49 mg, 0.077 mmol, 62%). 31: colorless oil; Rf “  0,34 
(silica, 30% ether in petroleum ether); IR (film) vmix 2940,2850,1420, 
1100, 860, 840, 740, 705, 610 cm**1; *H NMR (250 MHz, CDC13) 6 
7.65-7.35 (m, 10 H, ArH), 3.76 (m, 1 H, OCH), 3.59 (m, I H, OCH), 
3.40-2.94 (m, 8  H, OCH), 2.50 (m, 2 H, CH2C-C), 2.23-1.20 (m, 
16 H, CH), 1.01 (s, 9 H, f-Bu), 0.02 (s, 9 H, Si(CH3)3); HRMS (FAB), 
calcd for C37H37 0 3Si2 (M +  H+) 637.3744, found 637.3661,
Oxepanone 32. A stirred solution of oxepene 31 (41 mg, 0.060 
mmol) in THF (1.5 mL) was treated with tetra-n-butylammonium 
fluoride (0.2 mL of a 1.0 M in THF, 0.20 mmol) at 50 °C for 10 h. 
The solvent was evaporated and the residue subjected to flash 
chromatography (silica, 50-~80% ether in petroleum ether) to give 
oxepanone 32 (19 mg, 0.064 mmol, 94%). 32: colorless oil; Rf =  
0.51 (silica, 100% ether); [a]22D -22,8 (c 0.05, CH2C12); IR (film) v*** 
3460, 2940, 2870, 1715, 1440, 1380,1100, 985, 960, 735, 705 cm’ 1; 
>H NMR (250 MHz, CDCU) 6 3.82 (m, 3 H, OCH), 3.24 (m, 4 H, 
OCH), 2.92 (m, 2 H, OCH), 2.82 (m, 1 H, CH2C(0)), 2,31 (m, 1 H, 
CH2C(0)), 2.12-1.82 (m, 6  H, CH, OH), 1.71-1.20 (m, 9 H. CH); 
HRMS (FAB), calcd for C16H270 5 (M + H*) 299.1858, found 299.1844.
Oxepane 42. A solution of hydroxy ketone 39 (81 mg, 0.39 mmol) 
and triethylsilane (0.60 mL, 3.90 mmol) in CH2C12 (2 mL) was treated 
at 0 °C with trimethylsilyl trifluoromethanesulfonate (70 /¿L, 0.39 
mmol). After 15 min, aqueous saturated sodium bicarbonate (2 mL) 
was added and the mixture was diluted with ether (10 mL), washed 
with H20  ( 2  mL), dried (MgSO*), concentrated, and chromatographed 
(silica, 5% ether in petroleum ether) to give oxepane 42 (63 mg, 0.033 
mmol, 85%). 42: colorless oil; Rf= 0.55 (silica, 5% ether in petroleum 
ether); IR (film) 2913, 2843, 1452, 1103, 700 cm-1; !H NMR 
(250 MHz, CDCI3) <5 7.37-7.16 (m, 5 H, ArH), 4.55 (dd, J =  8 .8 , 3.9 
Hz, 1 H, OCH), 3.83 (m, 1 H, OCH), 2.05-1.99 (m, 2  H, CH), 1.87“
I.58 (m. 6  H, CH), 1.21 (d, J = 6.2 Hz, 3 H, CH3); HRMS (FAB), 
calcd for C(3HI90  (M + H+) 191.1436, found 191.1422.
Dioxepane 47. Dioxepane 47 was prepared following the same 
procedure as for 42 from hydroxy ketone 32 (42 mg, 0.15 mmol). Flash
chromatography (silica, 40% ether in petroleum ether) gave oxepane 
47 (34 mg, 0.12 mmol, 8 8 %) as a 4:1 mixture of trans/cis Isomers, 
trans-4 7: colorless needles; mp 90-91 °C (ether/hexanes); Rf— 0.38 
(silica, 50% ether in petroleum ethtr); IR (film) 2955,2860,1470, 
1325, 1280,1080, 1022, 965.745 cm“‘; *H NMR (500 MHz, CgD*) «5
3.85 (m, 2 H, OCH), 3.52 (m, 2 H, OCH), 3.24 (m. 2 H, OCH), 3.08 
(m, 2  H, OCH), 2.95 (m, 2  H, OCH), 2.00 (m, 4 H, CH), 1.72 (m, 6
H, CH), 1.65 (m, 6  H, CH); ,3CNMR (125 MHz, CDC13) 6 82.8,82.6,
82,4,67.7,31.3,30.0,28.8,25.9; HRMS (Cl), calcd for Ci6H260 4 (M+) 
282.1831, found 282.1854. c«-47i white solid; mp 95—96 °C (ether/ 
hexanes); Rf  ** 0.35 (silica, 50% ether in petroleum ether) IR (film) 
Vmu 2948, 2860,1448,1345, 1219, 1140, 1110, 1086, 1062, 968, 736 
cm-1; !H NMR (500 MHz, CDC13) <5 3,90-3.78 (m, 4 H, OCH), 3,39- 
2.76 (m, 6  H, OCH), 2,06-1.22 (m, 16 H, CH); l3C NMR (125 MHz, 
CDCI3) d 85.3, 84.8, 82,7, 82.6, 82,0, 79.9, 71.6, 67,7, 67.0, 32.1, 31.8,
Total Synthesis of Brevetoxin B. 1 I  Am, Chem. Soc., Vol. 117, Afo. 47, 1995 10237
29.3, 27.9, 26.9, 26.8, 26.3, 25.9; HRMS (FAB), calcd for CwHjA  
(M +  H+) 283.1909, found 283.1901.
Alcohol 64. To a stirred solution of ester 63 (11.5 g, 18.4 mmol) 
in THF (40 mL) at 25 °C was added dropwise tetra-n-butylammonium 
fluoride (27.6 mL of a 1.0 M solution, 27,6 mmol). After 30 min, the 
reaction mixture was diluted with ether (200 mL), washed with brine 
(140 mL), and dried (MgSOO and the solvent was evaporated. Flash 
chromatography (silica, 30—70% ether in petroleum ether) gave the 
epoxy alcohol 64 (9,0 g, 17.6 mmol, 96%). 64: colorless oil; R/ = 
0.38 (silica, 70% ether in petroleum ether); [a]a D +49.8 (c 4.2, 
CH2C12); IR (film) Vjmx 3490, 2960, 1715, 1660, 1460, 1370,920,730, 
700 cm“1; 'H NMR (250 MHz, CDCI3) 6 7.33 (m, 10 H, ArH), 6.29 
(d, J «  8 . 8  Hz, 1 H, -CH), 4.63 (d, J =  11.7 Hz, 1 H, CtfHPh), 4.57 
(d, J =  12.4 Hz, 2 H, CH2Ph), 4.40 (d, J =  11.7 Hz, 1 H, CHHPh), 
4.18 (q, J =  7.3 Hz, 2 H, CO2C//2CH3), 3.83-3.52 (m, 3 H, OCH), 
3.49-3.25 (m, 4 H, OCH), 2.45 (d, J =  5.4 Hz, 1 H, OH), 2.36 (m, 1
H, CH), 2.14-2.00 (m, 1 H, CH), 1.98 (d, J =  1.3 Hz, 3 H,CH3C-C),
I.75-1.60 (m, 1 H, CH), 1.28 (t, /  =  7.3 Hz, 3 H, C02CH2C//3), 1 . 2 2  
(s, 3 H, CH3); HRMS (Cl), calcd for C30H38O7 (M+) 510.2779, found 
510.2617.
Bicycle 65. A solution of epoxy alcohol 64 (8.9 g, 17.5 mmol) in 
CH2CI2 (200 mL) at 0 °C was treated with pyridinium /Moluene- 
sulfonate (3.7 g, 14.8 mmol). After 13 h, triethylamine (2.5 mL) was 
added and the solvent was evaporated. Flash chromatography (silica, 
70% ether in petroleum ether) gave the cyclized product 65 (8.7 g,
17.1 mmol, 97%). 65: colorless oil; R /=  0.32 (silica, 70% ether in 
petroleum ether); [a]22D +42.6 (c 1.9, CH2CI2); IR (film) 3480, 
2960, 2880, 1715, 1665, 1500,1460,1375,1270, 1070, 915, 750,700 
cm-1; >H NMR (250 MHz, CDCI3) 6 7.33 (m, 10 H, ArH), 6.67 (d, J 
=  8 . 8  Hz, 1 H, -CH), 4.68 (d, J =  11.7 Hz, 1 H, CHHPh), 4.60 (d, 
J =  4.5 Hz, 1 H, CtfHPh), 4.55 (d, J = 4.5 Hz, 1 H, CtfHPh), 4.39 (d, 
J =  11.7 Hz, 1 H, C/fHPh), 4.20 (q, J = 7.3 Hz, 2 H, C02Cff2CH3), 
4.03 (t, J =  9.0 Hz, 1 H, OCH), 3.80-3.45 (m, 5 H, OCH), 3.20 (dd, 
J =  12.6, 3.9 Hz, 1 H, OCH), 2.36-2.28 (m, 2 H, CH), 2.12 (m, 1 H, 
OH), 1,98 (d, J »  1.3 Hz, 3 H, CH3C—C), 1.70-1.50 (m, 2 H, CH),
1.32 (t, J =  7.3 Hz, 3 H, C02CH2Ctf3), i ‘30 (s, 3 H, CH3); HRMS 
(Cl), calcd for C30H42O7N (M +  NH4+) 528.2961, found 528.2921.
Saturated Ester 6 6 . A mixture of ester 65 (8 . 6  g, 16.9 mmol) and 
10% Pd/C (1.7 g, 20% by weight) in EtOAc (45 mL) was stirred under 
a H2 atmosphere for 48 h at 25 °C. The mixture was filtered through 
Celite and the filtrate was concentrated to give a diastereomeric mixture 
of esters 6 6  (8 . 6  g, 16.8 mmol, 100%). 6 6 : colorless oil; R/ =  0.28 
(silica, 70% ether in petroleum ether); IR (film) Van* 3470,2960,2880, 
1730, 1460, 750, 700 cm“1; !H NMR (250 MHz, CDCI3) d 7.33 (m, 
10 H, ArH), 4.56 (m, 3 H, CH2Ph), 4.35 (d, J = 12.4 Hz, 1 H, CtfHPh), 
4.09 (q, J = 7.3 Hz, 2 H, C02Ctf2CH3), 3.63 (m, 2 H, OCH), 3.45 (m, 
3 H, OCH), 3.04 (m, 2 H, OCH), 2.71 (m, i H, CH), 2.52 (m, 1 H, 
OH), 2.21 (m, 3 H, CH), 1.51 (m, 3 H, CH), 1.25-1.15 (m, 9 H, 2 x 
CH3, C02CH2Ctf3); HRMS (Cl), calcd for C30H44O7N (M + NH^) 
530.3118, found 530.3163.
2-(Trimethylsilyl)ethyl Ester 67. A solution of ester 6 6  (8.5 g, 
16.6 mmol) in THF (45 mL) was added to a stirred solution of 
2-(trimethylsilyl)ethanol (11,9 mL, 83 mmol) and potassium hydride 
(0.1 g, 2.5 mmol) in THF (50 mL) at 25 °C. After 15 min, MeOH (1 
mL) was added and the reaction mixture was diluted with ether (200 
mL), washed with water (100 mL), dried (MgSO*) and concentrated. 
Excess 2 -(trimethylsilyl)ethanol was removed by azeotroping with 
toluene. Flash chromatography (silica, 50% ether in petroleum ether) 
gave the silyl ester 67 (8 . 8  g, 15.1 mmol, 91%) as a 1 :1  mixture of 
diastereoisomers. 67: colorless oil; R /=  0,15 (silica, 50% ether in 
petroleum ether); IR (film) v ^  3460, 2960, 2880, 1725, 1500, 1465, 
845, 740, 700 cm“1; ’H NMR (250 MHz, CDC13) <5 7,33 (m, 10 H. 
ArH), 4.56 (m, 3 H, CH2Ph), 4,32 (d, /  =  12.4 Hz, 1 H, CtfHPh), 4.13 
(m, 2 H, OCH), 3.63 (m, 2 H, OCH), 3.44 (m, 3 H, OCH), 3.05 (m, 2
H, OCH), 2.73 (m, 1 H, CH), 2.25 (m, 4 H, CH, OH), 1.51 (m, 3 H, 
CH), 1.18 (m, 6  H, 2 x CH3), 0.90 (t, J =  8.1 Hz, 2 H, CH2Si), 0,05 
(s, 9 H, Si(CH3)3); HRMS (Cl), calcd for C33H320 7 SiN (M + NH*+) 
602,3513, found 602.3471, Anal. Calcd for C33H4i0 7 Si: C, 65.74;
H, 7.97, Found: C, 66.07; H, 8.11.
Dithionoester 70. Dithionoester 70 was prepared following the same 
procedure as for 20 from the corresponding diester 6926 (347 mg, 0.35 
mmol). Flash chromatography (silica, 1CH“30% ether in petroleum
ether) gave dithionoester 70 (208 mg, 0.20 mmol, 58%) as a 1:1 mixture 
of diastereoisomers. 70: colorless oil; Rf =  0.68 (silica, 20% ether in 
petroleum ether); IR (film) Vm« 2960, 2860, 1595, 1455, 1430, 860, 
840, 740, 700, 610 cnT>; >H NMR (250 MHz, CDCl3) <3 7.80-7.25 
(m, 20 H, ArH), 5.38 (m, 1 H, CHO(S)C), 4.68-4,30 (m, 6  H, CH2Ph, 
CH20(S)C), 3.74-3.00 (m, 9 H, OCH), 2.70-1.14 (m, 20 H, CH2C(S), 
CH), 1.30 ( 2  x s, 6  H, 2 x CH3), 1.00 (s, 9 H, /-Bu), 0.04 (s, 9 H, 
Si(CH3)3); HRMS (Cl), calcd for C3jH8oOgS2Si2 (M+) 1024,4833, found 
1024,4824.
Oxepene 71. Oxepene 71 was prepared following the same 
procedure as for 23 from dithionoester 70 (167 mg, 0.16 mmol). Flash 
chromatography (silica, 10—30% ether in petroleum ether) gave 
oxepene 71 (110 mg, 0 , 1 2  mmol, 72%) as a 1 :1  mixture of diastereo­
isomers. 71: colorless oil; Rf = 0.42 (silica, 30% ether in petroleum 
ether); IR (film) vmw 2960, 2860, 1460, 1380, 1245, 1 1 0 0 , 865, 840, 
740, 705,615 cm '1; 'H NMR (250 MHz, CDC13) 6 7.80-7.25 (m, 20
H, ArH), 5.38 (m, 1 H, CHO(S)C), 4.63 (d, J =  11,5 Hz, 1 H. CffHPh),
4.58 (d, J »  11.4 Hz, 2 H, CtfHPh), 4.39 (d, J = 11.5 Hz, 1 H, 
CtfHPh), 3.74-3.05 (m, 12 H, OCH), 2.70-2.50 (m, 2 H, CH), 2.32 
(m, 4 H, CH), 1.93-1.46 (m, 12 H, CH), 1.24,1.11 (s, 3 H, CH3), 1.07 
(d, /  =  6.3 Hz, 3 H, CH3), 1.00 (s, 9 H, /-Bu), 0.01 (s, 9 H, Si(CH3)3); 
HRMS (FAB), calcd for CjBH«0 *Si2 (M + H+) 961.5470, found 
961.5466.
Oxepanone 72. Oxepane 72 was prepared following the same 
procedure as for 32 from oxepene 71 (96 mg, 0.10 mmol). Flash 
chromatography (silica, 40-*80% ether in petroleum ether) gave 
oxepanone 72 (55 mg, 0.088 mmol, 8 8 %) as a single isomer. 72: 
colorless oil; Rf = 0.60 (silica, 100% ether); [<x]22d -18.2 (c 0.95, 
CH2C12); IR (film) vmtt 3450,1715 cm“1; lH NMR (500 MHz, CDC13) 
<5 7.54-7.24 (m, 10 H, ArH), 4.62 (d, J = 11.5 Hz, I H, CHHPh), 
4.54 (d, J = 12.0 Hz, 1 H, CtfHPh), 4,52 (d, J = 11.5 Hz, I H, 
CHHPh), 4.38 (d, J =  12.0 Hz, 1 H, CtfHPh), 3.80 (m, 1 H, OCH), 
3.70-3.00 (m, 11 H, OCH), 2.30-1.50 (m, 14 H, CH), 1,15 (s, 3 H, 
CH3), 1.09 (s, 3 H, Cft), 1.05 (d, J = 7.3 Hz, 3 H, CH3); 13C NMR 
(125 MHz, CDC13) 6 216.9, 138.0, 137,9, 128.3, 128.3, 128.3, 128.3,
128.2, 127.7, 127.7, 127.7, 127.7, 127.4, 87.7, 81.4, 77.9, 77.7, 75.9,
73.3, 73.1, 72.5, 72.3, 71.6, 71.0, 69.6, 60,5, 44.6, 38.5, 37.9, 34.0,
30.2,29.6,27.6,26.5,24.0,16.3, 15.2; HRMS (Cl), calcd for C37H5QO* 
(M+) 622.3505, found 622.3540.
Dioxepane 73. Compound 73 was prepared following the same 
procedure as for 42 from hydroxy ketone 72 (50 mg, 0.08 mmol) and 
'diphenylmethylsilane (0.80 mmol). Flash chromatography (silica, 30% 
ether in petroleum ether) gave dioxepane 73 (30 mg, 0.050 mmol, 62%) 
as a 6:1 mixture of trans/cis isomers, trans-73: colorless oil; R f  =  
0.77 (silica, 80% ether in petroleum ether); IR (film) Vm« 2950,2830, 
1470, 1110, 750 cm“1; JH NMR (500 MHz, C6D6) (5 7.54-7,24 (m,
10 H, ArH), 4.54 (d, J = 12.3 Hz, 1 H, CtfHPh), 4.45 (d, J = 12.3 
Hz, 1 H, CtfHPh), 4.45 (d, J «  11.8 Hz, 1 H, CtfHPh), 4.29 (d, J =
11.8 Hz, 1 H, CHHPh), 3.80-3.39 (m, 6  H, OCH), 3.32 (dd, J «  7.7,
4.5 Hz, 1 H, OCH), 3.74 (m, 2  H, OCH), 3.54 (m, 1 H, OCH), 3.46 
(m, 1 H, OCH), 3.21-2.92 (m, 4 H, OCH), 2.36-1.21 (m, 12 H, CH),
I.15 (s, 3 H, CH3). 1.09 (s, 3 H, CHj), LOO (d, J = 6.3 Hz, 3 H, CH3); 
HRMS (Cl), calcd for C37H50O7 (M+) 606.3556, found 606,3525.
Carboxylic Acid 83. A stirred solution of ester 82 (16.2 g, 28.4 
mmol) in THF:Me0H:H20  (1:1:1, 60 mL) was treated with lithium 
hydroxide (1.4 g, 46.8 mmol) and heated at 55 °C for 2.5 h. The 
reaction mixture was cooled, diluted with EtOAc (200 mL), and 
carefully acidified with 2 N aqueous hydrochloric acid to pH 5. The 
organic layer was separated and the aqueous layer was extracted with 
EtOAc (2 x 50 mL). The extracts were combined, dried (MgSO^), 
and concentrated to give the carboxylic acid 83 (14.8 g, 26,6 mmol, 
94%), 83: colorless oil; Rf = 0.44 (silica, 50% ether in petroleum 
ether); [a]22D +1.1 (c 0.6, CH2C12); IR (film) 3400, 2970, 2860, 
1710, 1620, 1580, 1460, 1370, 1260, 1100, 870, 840, 780, 740, 700 
cm“1; ’H NMR (2}0 MHz, CDC13) 6 7.54-7.24 (m, 10 H, ArH), 4.53 
(d, /  -  IL 8 Hz, 1 H, CHHPh), 4.44 (m, 3 H, CH2Ph), 3.53 (m, 2 H, 
OCH), 3.30 (m, 2 H, OCH), 2.29 (t, J = 8.0 Hz, 2 H, CH2C(0)), 1.91 -
1.59 (m, 6  H, CH), 1.16 (s, 3 H, SiCH3), 1.10 (s, 3 H, SiCH3), 0.82 (s,
9 H, /-Bu), -0.01 (s, 6  H, 2 x CH3); HRMS (FAB), calcd for C32H490 6« 
Si (M + H+) 557,3298, foiind 557.3271, Anal. Calcd for Cs^aOs- 
Si: C, 69,06; H, 8.63. Found: C, 69.00 H, 8.57,
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Diester 84. A stirred solution of alcohol 67 (2,4 g, 4.1 mmol), acid 
83 (2.3 g, 4.1 mmol), N,iV-dimethyl-4-aminopyridine (150 rag, 1.23 
mmol) and camphorsulfonic acid (404 mg, 1.23 mmol) in CH2C12 (15 
mL) at 25 °C was treated with 1,3-dicyclohexylcarbodiimide (1.3 g, 
6.2 mmol). After stirring for 10 h at 25 °C, ether (30 mL) was added 
and the mixture was filtered through Celite. Concentration and flash 
chromatography (silica, 20% ether in petroleum ether) gave diester 84 
(4.1 g, 3.7 mmol, 8 8 %) as a 1:1 mixture of diastereoisomers. 84: 
colorless oil; ƒ?/= 0.44 (silica, 30% ether in petroleum ether); IR (film) 
v„ux 2940, 2840, 1730, 1490, 1445, 1365, 1245, 855, 830, 770, 730, 
690 cm“1; *H NMR (250 MHz, CDCI3) <5 7.54-7.24 (m, 20 H, ArH), 
4.69 (m, 1 H, OCH), 4.62-4.30 (m, 8  H, CH2Ph), 4.14 (m, 2 H, OCH), 
3.68—3.21 (m, 8  H, OCH), 3.04 (m, 2 Ht OCH), 2.65 (ra, I H, 
CHHC(O)), 2.30-1.46 (m, 14 H, CH), 1.28 (s, 3 H, CH3), 1.20 (s, 3
H, CH3), 1.09 (s, 3 H, CH3), 1.05 (d, J  «  6.3 Hz, 3 H, CHj), 0.95 (m,
2 H, CH2Si), 0.86 (s, 9 H, /-Bu), 0.03 (s, 3 H, SiCH3), 0.02 (a, 3 H, 
SiCH3), 0.01 (s, 9 H, Si(CH3)3); HRMS (FAB), calcd for C65HM0 ,2Si2 
(M + H+) 1123.6361, found 1123.6245.
Dithionoester 85. Dithionoester 85 was prepared following the same 
procedure as for 69 from diester 84 (3.5 g, 3.1 mmol). Flash 
chromatography (silica, 10—’30% ether in petroleum ether) gave 
dithionoester 85 (2.0 g, 1.73 mmol, 56%) as a 1:1 mixture of 
diastereoisomers. 85: colorless oil; R f  =  0.76 (silica, 2 0 % ether in 
petroleum ether); IR (film) v„ux 2950, 2850, 1495, 1455, 1375, 1240, 
1085, 860, 835, 775, 730, 700 cm“1; *H NMR (250 MHz, CDCl3) <5
7.54-7.24 (m, 2 0  H, ArH), 5.40 (m, 1 H, C(S)OCH), 4.63-4.30 (m,
10 H, CH2Ph, C(S)OCH2), 3.69-3.00 (m, 10 H, OCH), 2.72-1.41 (m, 
15 H, CH), 1.29 (s, 3 H, CH3), 1.21 (s, 3 H, CH3), 1.14 (d, J  = 6.3 Hz,
3 H, CH3), 1.13 (s, 3 H, CH3), 1.07 (m, 2 H, CH2Si), 0.88 (s, 9 H, 
/-Bu), 0.04 (s, 3 H, SiCH3), 0.01 (s, 3 H, SiCHj), 0.00 (s, 9 H, Si(CH3)3); 
HRMS (FAB), calcd for CwHwOioSaSi* (M +  H+) 1155.5905, found 
1155.5772.
Oxepene 8 6 - Oxepene 8 6  was prepared following the same 
procedure as for 8 6  from dithionoester 85 (1.5 g, 1.3 mmol). Flash 
chromatography (silica, 10—30% ether in petroleum ether) gave 
oxepene 8 6  (0.91 g, 0.83 mmol, 64%) as a 1:1 mixture of diastereo* 
isomers. 8 6 : colorless oil; Rf  =  0.33 (silica, 30% ether in petroleum 
ether); IR (film) v*« 2950,2920,2860,1500,1455,1380.1365,1250, 
1075, 860, 835, 775, 730, 700 cm“1; 'H NMR (250 MHz, CDCl3) <5
7.54-7.24 (m, 20 H, ArH), 4.63-4.37 (m, 8 H, CH;Ph), 3.71-3.01 
(m, 13 H, OCH), 2.29 (m, 1 H, CH), 1.90-1.54 (m, 14 H, CH), 1.29 
(s, 3 H, CH3), 1.22 (s, 3 H, CH3), 1.14 (s. 3 H, CH3), 1.09 (d, J  *  6.3 
Hz, 3 H, CH3), 1.01 (m, 2 H, CH2Si), 0.82 (s, 9 H, /-Bu), 0.04 (s, 3 H, 
SiCH3), 0.01 (s, 3 H, SiCH3), 0.00 (s, 9 H, Si(CH3)3); HRMS (FAB), 
calcd for C6jHwOioSi2Na (M +  Na+) 1113.6283, found 1163.6162.
Hydroxy Ketone 87. A stirred solution of oxepene 8 6  (870 mg, 
0.80 mmol) in THF (1.5 mL) was treated with tetra-fl-butyl ammonium 
fluoride (2.4 mL of a 1.0 M solution in THF, 2.4 mmol). The reaction 
mixture was heated at 50 °C for 10 h and evaporated and the residue 
was subjected to flash chromatography (silica, 30 — 50% ether in 
petroleum ether) to give hydroxy ketone 87 (640 mg, 0.73 mmol, 91%) 
as a single diastereoisomer, 87: colorless oil; Rf  = 0.21 (silica, 70% 
ether in petroleum ether); [ cl] 22d  -21.4 (r 0.7, CH2C12); IR (film) v*** 
3460, 2960, 2880, 1715, 1500, 1460, 1370, 915, 735, 700 cm“1; lH 
NMR (250 MHz, CDCI3) 6 7.54-7.24 (m, 20 H, ArH), 4.61-4.33 
(m, 8  H, CH2Ph), 3.72 (m, 1 H, OCH), 3.63 (bs, 3 H, OCH), 3.55- 
3.42 (m, 5 H, OCH), 3.14-2.90 (m, 3 H, OCH), 2.37-1.51 (m, 16 H, 
CH, OH), 1.18 (s, 3 H, CH3), 1.15 (s, 3 H, CH3), 1.12 (s, 3 H, CH3),
I.05 (d, J  =  6.3 Hz, 3 H, CH3); HRMS (FAB), calcd for C^HmOio 
(M + H+) 877.4888, found 877.4957. Anal, Calcd for C ^aO jo: 
C, 73.97; H, 7.76. Found: C, 73.69; H, 7.94.
Compound 89. To a stirred solution of hydroxy ketone 87 (560 
mg, 0.69 mmol) and diphenylmethylsilane (0.5 mL, 2.4 mmol) in 
CH2C12 (10 mL) at 0  °C was added trimethyl silyl trifluoromethane- 
sulfonate (125 /¿L, 1.04 mmol). After 40 min, saturated aqueous sodium
bicarbonate ( 1  mL) was added and the mixture was diluted with ether 
(30 mL), washed with water (5 mL), dried (MgSOi), and concentrated. 
Flash chromatography (silica, 30% ether in petroleum ether) gave 
compound 89 (275 mg, 0.32 mmol, 46%). 89: colorless oil; R f  = 0.62 
(silica, 50% ether in petroleum ether); [cx322d +17.7 (c 0.2, CH2C12); 
IR (film) 2920, 2850,1490, 1450,1370, 1070, 730, 690 cm”1; 'H 
NMR (250 MHz, CDC13) <5 7.54-7.24 (m, 20 H, ArH), 4.62-4.34 
(m, 8  H, CH2Ph), 4.18 (dd, J  = 8 ,6 , 2.1 Hz, 1 H, OCH), 3.88 (t, J  =
8 . 8  Hz. 1 H, OCH), 3.69-3.41 (m, 5 H, OCH), 3.31 (ra, 2 H, OCH), 
3.20-3.10 (m, 1 H, OCH), 3.00 (dd, J  =  10,4, 3.2 Hz, 1 H, OCH), 
2.29-1.52 (m, 15 H, CH), 1.22 (s, 3 H, CH3), 1.18 (s, 3 H, CH3), 1.07 
(s, 3 H, CH3), 1.04 (d, J  =  6.3 Hz, 3 H, CH3); HRMS (FAB), calcd for 
CwHiA (M + H+) 861.4941, found 861.4943.
Benzoate 91. To a solution of the appropriate alcohol precursor of 
91 (25 mg, 0.05 mmol) and //,W-dimethyM-aminopyridine (12 mg,
0.1 mmol) in CH2G 2 (1 mL) was added p-nitrobenzoyl chloride ( 1 1  
mg, 0.06 mmol). After 20 min, MeOH (0.1 mL) was added and the 
reaction mixture was concentrated. Flash chromatography (silica, 30% 
ether in petroleum ether) gave the benzoate ester 91 (32 mg, 43 ^mol, 
8 6 %), 91: white solid, mp 168-170 °C (pentane/CH2Cl2); /? /-  0,22 
(silica, 70% ether in petroleum ether); [ cx] 22d  -18.0 ( c  0,06, CH2C12); 
IR (CH2C12) Vmix 2935,1725,1530,1385,1350,1270,1090, 910, 860 
cm“1; !H NMR (250 MHz, CDC13) 6 8.28 (d, J *  8.9 Hz, 2 H, ArH), 
8.12 (d, J  =  8.9 Hz, 2 H, ArH), 5.62 (dd, J  =  17.4, 10.6 Hz, 1 H, 
CH-), 5.35 (m, 1 H, CH02C), 5.31 (d, J  = 17.4 Hz, 1 H, GHH-),
5.17 (d, J  =  10.6 Hz, 1 H, CffH-), 4.38 (t, 7 = Hz, 1 H, OCH), 3.82 
(dd, J  =  10.2, 4.1 Hz, 1 H, OCH), 3.64 (t, J  =  Hz, 1 H, OCH), 3.54 
(m. 3 H, OCH), 3.36 (m, 2 H, OCH), 3.10 (m, 1 H, OCH), 2.94 (dd, 
/  =  7.2, 3,2 Hz, 1 H, OCH), 2.11-1.57 (m, 15 H, CH), 1.47 (s, 3 H, 
CH3), 1.38 (s, 3 H, CH3), 1,25 (s, 3 H, CH3), 1.19 (s, 3 H, CHs), 1.08 
(s, 3 H, CH3), 0,94 (d, J  =  6.3 Hz, 3 H, CH3); HRMS (Cl), calcd for 
C4oH330 ,2N (M + NH*+) 741.3724, found 741.3741.
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